首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Ejhaem

缩写:

ISSN:2688-6146

e-ISSN:2688-6146

IF/分区:1.3/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引1401条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Joseph Taylor,Tasneem Lakum,Shaun Bevan et al. Joseph Taylor et al.
Background: Molecular T-cell receptor (TCR) clonality testing cannot link clonality to immunophenotype, limiting discrimination between malignant and clonal reactive T-cell expansions. ...
Moushumi Suryavanshi,Prashant Mehta,Nitin Jain et al. Moushumi Suryavanshi et al.
Background: Measurable residual disease (MRD) monitoring is a critical component of risk stratification and therapeutic decision-making in B-cell acute lymphoblastic leukemia (B-ALL). Multiparameter flow cytometry (MFC) i...
Kiyoyuki Ogata,Yuto Mochimaru,Leonie Saft et al. Kiyoyuki Ogata et al.
Background: Cytomorphological examination and classification of bone marrow (BM) cells using a microscope is essential for diagnosing various diseases affecting the haematopoietic system. However, this requires expertise,...
Ahmed Al-Djaber,Arielle Munters,Jörg Cammenga et al. Ahmed Al-Djaber et al.
Background: Genomic profiling of patients with myeloid neoplasms (MN) may detect variants with high variant allele frequency (VAF), indicating potential germline origin. All current guidelines recommend further investigat...
Mohamad Sheikh Najeeb,Oudai Alkabbani,Rong He et al. Mohamad Sheikh Najeeb et al.
Background: IDH mutations are found in 15%-20% of acute myeloid leukemia (AML). Recent evidence suggests that IDH mutation subtypes may respond differently to intensive chemotherapy. We evaluated blast clearance patterns,...
Teng Wang,Siyuan Cui,Jingyi Wang et al. Teng Wang et al.
Background: Multiple myeloma (MM) is a genetically heterogeneous malignancy in which cytogenetic abnormalities critically influence prognosis. The prognostic significance of 17p gain/amplification (17p+), particularly rel...
Tatsuki Morioka,Shoya Arai,Yumi Arai et al. Tatsuki Morioka et al.
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disorder treated with complement C5 inhibitors. While eculizumab (Ecu) has documented safety in pregnancy, data on ravulizumab (Rav) are scarce. We report a 25-year-old woman with PNH who ...
Christelle Le Gall-Ianotto,Lanig Civi,Brigitte Pan-Petesch et al. Christelle Le Gall-Ianotto et al.
Background: Aquagenic pruritus (AP) is a common and distressing symptom in myeloproliferative neoplasm (MPN) patients. Methods: This st...
Mahdiyeh Movahedi,Leila Moradi,Zahra Alizadeh et al. Mahdiyeh Movahedi et al.
Background: Severe congenital neutropenia (SCN) is commonly treated with granulocyte colony-stimulating factor (G-CSF) to reduce neutropenia and the associated risk of infections. Pegfilgrastim, a long-acting form of G-CS...
Jun Yen Ng,Arun Sr,Maansi Joshi et al. Jun Yen Ng et al.
DDX3X::MLLT10¸ which arises from t(X;10)(p11.4;p12.31), is infrequently observed in adult acute myeloid leukaemia (AML). The clinical and pathological characteristics are also not well characterised, detailed in only two cases published to...